电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

GSC2 蛋白

(Goosecoid Homeobox 2 (GSC2))
Goosecoidlike (GSCL), a homeodomain-containing gene, resides in the critical region for VCFS/DGS on 22q11. Velocardiofacial syndrome (VCFS) is a developmental disorder characterized by conotruncal heart defects, craniofacial anomalies, and learning disabilities. VCFS is phenotypically related to DiGeorge syndrome (DGS) and both syndromes are associated with hemizygous 22q11 deletions. Because many of the tissues and structures affected in VCFS/DGS derive from the pharyngeal arches of the developing embryo, it is believed that haploinsufficiency of a gene involved in embryonic development may be responsible for its etiology. The gene is expressed in a limited number of adult tissues, as well as in early human development. [provided by RefSeq, Jul 2008].

3 results

custom-made GSC2 宿主: 人 宿主: HEK-293 Cells Recombinant > 90 % as determined by Bis-Tris PAGE, anti-tag ELISA, Western Blot and analytical SEC (HPLC)
产品编号 ABIN7548210
 
custom-made GSC2 宿主: 人 宿主: Cell-free protein synthesis (CFPS) Recombinant approximately 70-80 % as determined by SDS PAGE, Western Blot and analytical SEC (HPLC). ELISA, SDS, WB
产品编号 ABIN3081229
 
GSC2 宿主: 人 宿主: 大肠杆菌(E. Coli) Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
产品编号 ABIN5505649
 
  • 类型 Protein
    • Protein
  • 应用范围
    • Antibody Production (AbP)
    • ELISA
    • SDS-PAGE (SDS)
    • Standard (STD)
    • Western Blotting (WB)
  • 适用
    • Human
  • 图像
  • Carrier free only
  • 抗体来源
    • Cell-free protein synthesis (CFPS)
    • Escherichia coli (E. coli)
    • HEK-293 Cells
  • 抗原表位
    • AA 1-205
  • 标记
    • His tag
    • Strep Tag
  • 蛋白类型
    • Recombinant
  • Format
    • Liquid
  • Grade
    • custom-made
  • Supplier
    • antibodies-online
    • OriGene

Aliases for GSC2 蛋白

goosecoid homeobox 2 (Gsc2) 蛋白
goosecoid homeobox 2 (GSC2) 蛋白
goosecoid homebox 2 (Gsc2) 蛋白
4930568H22Rik 蛋白
GSC-2 蛋白
Gscl 蛋白
GSCL 蛋白
You are here:
Chat with us!